LIMNW vs TMO
Liminatus Pharma, Inc. Warrants (LIMNW) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
LIMNW does not have a complete income-statement cache yet.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
LIMNW currently screens at market cap $0. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the LIMNW and TMO stock pages for the full models.
Not investment advice.